The Europe COVID-19 diagnostics market continues to evolve in response to the ongoing need for robust testing strategies amid variant outbreaks and long-term surveillance. As per Expert Market Research, the market has been significantly driven by high testing volumes in countries like the United Kingdom and France, which conducted around 112 million and 58 million tests, respectivel, as of March 2021. Demand remains strong due to government-backed testing programs, technological advancements, and public health mandates.
Europe COVID-19 Diagnostics Market Share
The market is largely driven by PCR and antigen testing, with RT-PCR assay kits dominating the product category due to their high accuracy. The United Kingdom, Germany, and France collectively represent a major share of the European market, supported by well-established diagnostic infrastructure and proactive public health policies.
Leading companies such as Altona Diagnostics GmbH, Genomica S.A.U, and Primerdesign Ltd hold dominant positions due to their rapid innovation, CE-marked products, and reliable distribution channels. In terms of testing locations, hospitals and diagnostic centers lead, though point-of-care testing is gaining popularity, particularly in rural and underserved regions.
Europe COVID-19 Diagnostics Market Growth & Trends
Key Growth Drivers:
Continuous emergence of COVID-19 variants, necessitating frequent and rapid testing.
Government funding for mass testing initiatives and public-private partnerships.
Growth of travel-related testing as cross-border mobility resumes.
Advancements in sample collection and detection methods, increasing testing efficiency and accuracy.
Notable Trends:
Expansion of at-home testing kits, offering convenience and safety.
Integration of AI and machine learning in diagnostics for faster results and pattern detection.
Rising demand for multi-pathogen panels, allowing simultaneous testing for influenza, RSV, and SARS-CoV-2.
Shift towards non-invasive sample types such as saliva-based diagnostics.
According to Wikipedia, COVID-19 testing includes a range of methods such as molecular (RT-PCR), antigen, and antibody tests used to detect current or past infections, aiding in controlling outbreaks and informing public health decisions.
Europe COVID-19 Diagnostics Market Case Studies & News
Genomica S.A.U, a subsidiary of PharmaMar, partnered with the Spanish government to supply high-throughput RT-PCR testing solutions across hospitals.
Primerdesign Ltd launched its genesig® COVID-19 2G multiplex kit, which includes detection for both SARS-CoV-2 and internal controls, enhancing accuracy.
Clonit srl rolled out a new line of rapid antigen tests in Italy targeting professional use in urgent care settings.
BioMaxima SA in Poland expanded its diagnostic reagent production to meet increased local and export demands.
These examples reflect how companies across Europe are innovating to support testing scalability and accuracy amid fluctuating case numbers.
Europe COVID-19 Diagnostics Market Analysis
Market Dynamics:
As COVID-19 transitions from a pandemic to an endemic phase, diagnostic testing remains essential for healthcare preparedness, especially in detecting outbreaks in schools, workplaces, and long-term care facilities. However, the market may see moderate deceleration due to vaccination coverage and reduced mandatory testing in some countries.
Regulatory Landscape:
The European Medicines Agency (EMA) and national regulatory bodies have fast-tracked approvals for new diagnostic products during the pandemic. The IVDR regulation, effective from May 2022, is also reshaping the market by setting stricter compliance guidelines for in-vitro diagnostics.
Europe COVID-19 Diagnostics Market Segmentation
By Test Type:
PCR Test
Antigen Test
Antibody Test
Others
By Product:
RT-PCR Assay Kits
Immunoassay Test Strips
Others
By Sample Type:
Nasopharyngeal Swab
Oropharyngeal (OP) Swab
Nasal Swab
Blood Test
Others
By Business Model:
Point-of-Care (PoC) Testing
Non-Point-of-Care (PoC) Testing
By End Use:
Hospitals
Diagnostic Centres and Clinics
Laboratories
Others
By Region:
United Kingdom
Germany
Italy
France
Spain
Others
Europe COVID-19 Diagnostics Market Key Players
Altona Diagnostics GmbH
Genomica S.A.U
Clonit srl
BioMaxima SA
Primerdesign Ltd
Others
These companies continue to invest in R&D, cross-border collaborations, and scalable manufacturing, positioning themselves at the forefront of diagnostic innovation in Europe.
Browse More Reports
Healthcare Cloud Computing Market
Assisted Reproductive Technology Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
